Replies to post #120371 on Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

today's Eltropazine PR was meant to quell the sting of the newly minted 150-Mil. AS

$0.78 pps = $0.0052 pre-RS

a little histroy lesson in AMBS style financing meant to build shareholder value and create shareprice appreciation:


1-Bil. AS in August, 2014

1:150 RS in April, 2015

7.5-Mil. AS in May, 2015

13-Mil. AS in July, 2015

35-Mil. AS in August, 2015

150-Mil. AS in December, 2015

just what is this company doing

what are they doing

do they know 'anything' about shareholder friendly financing

or how to even obtain it ???

___________________________________________________________________________

Amarantus Appoints F. Randall Grimes, MBA as Director of Sponsored Research

September 13, 2013

http://www.amarantus.com/news/press-releases/detail/884/amarantus-appoints-f-randall-grimes-mba-as-director-of

SUNNYVALE, Calif., Sept. 13, 2013 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS) a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to neurodegeneration and apoptosis, today announced that it has appointed Mr. F. Randall Grimes, MBA as Director of Sponsored Research. Mr. Grimes will be focused on working with Amarantus' scientific team, Board of Advisors and outside collaborators to support the acquisition of non-dilutive funding from disease foundations, non-governmental and governmental organizations to advance Amarantus' pipeline.